Kristin Hodous | Investor Relations |
Jeff Albers | Chief Executive Officer |
Andy Boral | Chief Medical Officer |
Mike Landsittel | Vice President, Finance |
Marion Dorsch | Chief Scientific Officer |
Terence Flynn | Goldman Sachs |
Eric Schmidt | Cowen and Company |
Sarah Frank | Raymond James |
Dane Leone | BTIG |
Carmen Augustine | Jefferies |
Mike King | JMP Securities |
Arlinda Lee | Canaccord |
Good day, ladies and gentlemen, and welcome to the Q3 2017 Blueprint Medicines Corp. Earnings Conference Call. [Operator Instructions] As a reminder, this conference maybe recorded. I would like to introduce your host for today's conference, Kristin Hodous.
You may begin.